文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肿瘤中的 T 细胞干性和功能障碍是由一种共同的机制触发的。

T cell stemness and dysfunction in tumors are triggered by a common mechanism.

机构信息

Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

Center for Cell-Based Therapy, National Cancer Institute, Bethesda, MD 20892, USA.

出版信息

Science. 2019 Mar 29;363(6434). doi: 10.1126/science.aau0135.


DOI:10.1126/science.aau0135
PMID:30923193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8194369/
Abstract

A paradox of tumor immunology is that tumor-infiltrating lymphocytes are dysfunctional in situ, yet are capable of stem cell-like behavior including self-renewal, expansion, and multipotency, resulting in the eradication of large metastatic tumors. We find that the overabundance of potassium in the tumor microenvironment underlies this dichotomy, triggering suppression of T cell effector function while preserving stemness. High levels of extracellular potassium constrain T cell effector programs by limiting nutrient uptake, thereby inducing autophagy and reduction of histone acetylation at effector and exhaustion loci, which in turn produces CD8 T cells with improved in vivo persistence, multipotency, and tumor clearance. This mechanistic knowledge advances our understanding of T cell dysfunction and may lead to novel approaches that enable the development of enhanced T cell strategies for cancer immunotherapy.

摘要

肿瘤免疫学中的一个悖论是,浸润肿瘤的淋巴细胞在原位功能失调,但却具有类似于干细胞的行为,包括自我更新、扩增和多能性,从而导致大型转移性肿瘤的清除。我们发现,肿瘤微环境中钾的过度积累是这种二分法的基础,它触发了 T 细胞效应功能的抑制,同时保留了干细胞特性。高水平的细胞外钾通过限制营养物质的摄取来限制 T 细胞效应程序,从而诱导自噬和效应和衰竭部位组蛋白乙酰化的减少,这反过来又产生了具有改善体内持久性、多能性和肿瘤清除能力的 CD8 T 细胞。这种机制上的知识增进了我们对 T 细胞功能障碍的理解,并可能导致新的方法,使增强的 T 细胞策略能够用于癌症免疫治疗。

相似文献

[1]
T cell stemness and dysfunction in tumors are triggered by a common mechanism.

Science. 2019-3-29

[2]
PGE limits effector expansion of tumour-infiltrating stem-like CD8 T cells.

Nature. 2024-5

[3]
SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells.

J Immunother Cancer. 2020-6

[4]
Targeting /HP1γ Induces LEF-1 and IL-21R to Promote Tumor-Infiltrating CD8 T-Cell Persistence.

Front Immunol. 2021

[5]
Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.

J Clin Invest. 2018-8-6

[6]
Intratumoral Tcf1PD-1CD8 T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy.

Immunity. 2019-1-8

[7]
Metabolic Control of Epigenetics and Its Role in CD8 T Cell Differentiation and Function.

Front Immunol. 2019-11-26

[8]
Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen.

Nat Immunol. 2020-7-13

[9]
Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resection.

J Immunol. 2011-2-2

[10]
Tolerance and exhaustion: defining mechanisms of T cell dysfunction.

Trends Immunol. 2013-11-6

引用本文的文献

[1]
Noninvasive Mapping of Extracellular Potassium in Breast Tumors via Multi-Wavelength Photoacoustic Imaging.

Sensors (Basel). 2025-7-31

[2]
Mechanisms of T-cell metabolic reprogramming in the microenvironment of acute myeloid leukemia and its therapeutic potential (Review).

Oncol Lett. 2025-7-22

[3]
Tetrahydromagnolol induces autophagic cell death by targeting the mA reader protein YTHDF2 and enhances the efficacy of anti-PD-1 immunotherapy in pancreatic cancer cells.

Theranostics. 2025-7-2

[4]
Early methionine availability attenuates T cell exhaustion.

Nat Immunol. 2025-7-23

[5]
Selective expansion of TCF7-expressing tumor-reactive T cell subpopulations during ovarian tumor-infiltrating T cell production ex vivo.

Sci China Life Sci. 2025-7-8

[6]
Single-cell analysis reveals distinct immune characteristics of hepatocellular carcinoma in HBV-positive vs. HBV-negative cases.

Mol Clin Oncol. 2025-7-1

[7]
Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors.

Immunotargets Ther. 2025-6-27

[8]
Quadruplexes with a grain of salt: influence of cation type and concentration on DNA G4 stability.

Eur Biophys J. 2025-6-25

[9]
Bioactive metallic nanoparticles for synergistic cancer immunotherapy.

Acta Pharm Sin B. 2025-4

[10]
Targeting TBK1 potentiates oncolytic virotherapy via amplifying ICAM1-mediated NK cell immunity in chemo-resistant colorectal cancer.

J Immunother Cancer. 2025-6-8

本文引用的文献

[1]
Intratumoral Tcf1PD-1CD8 T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy.

Immunity. 2019-1-8

[2]
Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1CD8 Tumor-Infiltrating T Cells.

Immunity. 2019-1-8

[3]
Tales from the crypt: new insights into intestinal stem cells.

Nat Rev Gastroenterol Hepatol. 2019-1

[4]
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.

Cell. 2018-11-1

[5]
Two to Tango: Dialog between Immunity and Stem Cells in Health and Disease.

Cell. 2018-11-1

[6]
Acetate Production from Glucose and Coupling to Mitochondrial Metabolism in Mammals.

Cell. 2018-9-20

[7]
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.

Cell. 2018-6-28

[8]
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer.

Nat Med. 2018-6-4

[9]
Cancer immunotherapy using checkpoint blockade.

Science. 2018-3-23

[10]
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.

Cell Metab. 2017-7-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索